Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 20 of the 41 sources its claims cite were checked for support.

The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape

Open access
Fraser, Nicholas, Brierley, Liam, Dey, Gautam, Polka, Jessica K., Pálfy, Máté, Nanni, Federico, Coates, Jonathon Alexis · 2021 · PLOS Biology

Published version of a preprint

Abstract

The world continues to face a life-threatening viral pandemic. The virus underlying the Coronavirus Disease 2019 (COVID-19), Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has caused over 98 million confirmed cases and 2.2 million deaths since January 2020. Although the most recent respiratory viral pandemic swept the globe only a decade ago, the way science operates and responds to current events has experienced a cultural shift in the interim. The scientific community has responded rapidly to the COVID-19 pandemic, releasing over 125,000 COVID-19–related scientific articles within 10 months of the first confirmed case, of which more than 30,000 were hosted by preprint servers. We focused our analysis on bioRxiv and medRxiv, 2 growing preprint servers for biomedical research, investigating the attributes of COVID-19 preprints, their access and usage rates, as well as characteristics of their propagation on online platforms. Our data provide evidence for increased scientific and public engagement with preprints related to COVID-19 (COVID-19 preprints are accessed more, cited more, and shared more on various online platforms than non-COVID-19 preprints), as well as changes in the use of preprints by journalists and policymakers. We also find evidence for changes in preprinting and publishing behaviour: COVID-19 preprints are shorter and reviewed faster. Our results highlight the unprecedented role of preprints and preprint servers in the dissemination of COVID-19 science and the impact of the pandemic on the scientific communication landscape.

Overview

CoChat Summary

TL;DR

This paper analyzes bioRxiv and medRxiv preprints during the first 10 months of the COVID-19 pandemic, showing that COVID-19 preprints were posted in large numbers and accessed, cited, shared, and used in policy documents far more than non-COVID-19 preprints. It also finds that COVID-19 preprints were shorter and published in journals faster than non-COVID-19 preprints.

Key findings

  • By October 31, 2020, over 125,000 COVID-19 publications had appeared, including 30,260 preprints (~25%); bioRxiv and medRxiv hosted 10,232 COVID-19 preprints in the first 10 months, compared with 78 Zika virus and 10 Ebola virus preprints on bioRxiv during those outbreaks.
  • COVID-19 preprints on bioRxiv/medRxiv were accessed more (abstract views rate ratio = 18.2; PDF downloads rate ratio = 27.1), cited more (57.9% vs 21.5% received ≥1 citation; rate ratio = 13.7), tweeted more (98.9% vs 90.7% received >1 tweet; rate ratio = 7.6), covered in news more (28.7% vs 1.0%; rate ratio = 92.8), and commented on more (15.9% vs 3.1%; rate ratio = 11.0).
  • COVID-19 preprints were 32% shorter than non-COVID-19 preprints (median 3,965 vs 5,427 words) and were published faster after posting (median 68 vs 116 days; 48-day difference); 21.1% of COVID-19 preprints were published by end of October vs 15.4% of non-COVID-19 preprints.
  • Among COVID-19 corresponding authors, 85% were posting a bioRxiv/medRxiv preprint for the first time vs 69% of non-COVID-19 corresponding authors; 52 of 81 COVID-19 policy documents cited preprints, with medRxiv accounting for 209 of 255 preprint citations.

Methods

  • Retrieved bioRxiv and medRxiv metadata via API through October 31, 2020 (N = 114,214 overall); comparative analysis used 44,503 preprints posted January–October 2020, of which 10,232 (23.0%) were classified as COVID-19 by keywords in titles/abstracts, plus a January–December 2019 control set (N = 30,094).
  • Enhanced metadata with ROR affiliation matching, Crossref, Unpaywall, Dimensions citation data, Altmetric mentions, Disqus comment counts, and scraped bioRxiv/medRxiv usage data; policy analysis manually collected 81 COVID-19 and 38 non-COVID-19 policy documents.
  • Used chi-squared tests, Mann–Whitney tests, Spearman correlations, time-adjusted negative binomial regressions, and 2-way ANOVAs with Tukey HSD post hoc comparisons.

Limitations

  • Stated: COVID-19 classification relied on keyword matching of titles/abstracts at data extraction, so some early preprints revised to include COVID-19 keywords may have been captured; the tightly defined January–October 2020 window means preprints posted later had less time to accrue altmetric and usage metrics.
  • Stated: policy document analysis was limited to a small set largely restricted to Europe, and whether preprint use in policy extends more globally remains to be explored; word and reference counts were limited to bioRxiv because medRxiv did not display full HTML texts.
  • Evident: preprint publication status relied on bioRxiv/medRxiv DOI links and is likely an underestimate; Altmetric records only mentions it tracks, and missing responses were recorded as zero; the study is observational and does not establish causal effects of preprinting on later attention or publication outcomes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pbio.3000959

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Development of COVID-19 and publication response from January 1 to October 31, 2020. (A) Number of COVID-19 confirmed cases and reported deaths. Data are sourced from https://github.com/datasets/covid-19/, based on case and death data aggregated by the Johns Hopkins University Center for Systems Science and Engineering (https://systems.jhu.edu/). Vertical lines labelled (i) and (ii) refer to the date on which the WHO declared COVID-19 outbreak a Public Health Emergency of International Concern, and the date on which the WHO declared the COVID-19 outbreak to be a pandemic, respectively. (B) Cumulative growth of journal articles and preprints containing COVID-19–related search terms. (C) Cumulative growth of preprints containing COVID-19–related search terms, categorised by individual preprint servers. Journal article data in (B) are based upon data extracted from Dimensions (https://www.dimensions.ai; see Methods section for further details), and preprint data in (B) and (C) are based upon data gathered by Fraser and Kramer (2020). The data underlying this figure may be found in https://github.com/preprinting-a-pandemic/pandemic_preprints and https://zenodo.org/record/4587214#.YEN22Hmnx9A. COVID-19, Coronavirus Disease 2019; WHO, World Health Organization.
Fig 1 Development of COVID-19 and publication response from January 1 to October 31, 2020. (A) Number of COVID-19 confirmed cases and reported deaths. Data are sourced from https://github.com/datasets/covid-19/, based on case and death data aggregated by the Johns Hopkins University Center for Systems Science and Engineering (https://systems.jhu.edu/). Vertical lines labelled (i) and (ii) refer to the date on which the WHO declared COVID-19 outbreak a Public Health Emergency of International Concern, and the date on which the WHO declared the COVID-19 outbreak to be a pandemic, respectively. (B) Cumulative growth of journal articles and preprints containing COVID-19–related search terms. (C) Cumulative growth of preprints containing COVID-19–related search terms, categorised by individual preprint servers. Journal article data in (B) are based upon data extracted from Dimensions (https://www.dimensions.ai; see Methods section for further details), and preprint data in (B) and (C) are based upon data gathered by Fraser and Kramer (2020). The data underlying this figure may be found in https://github.com/preprinting-a-pandemic/pandemic_preprints and https://zenodo.org/record/4587214#.YEN22Hmnx9A. COVID-19, Coronavirus Disease 2019; WHO, World Health Organization.CC BY · PubMed Central
Fig 2 Comparison of the properties of COVID-19 and non-COVID-19 preprints deposited on bioRxiv and medRxiv between January 1 and October 31, 2020. (A) Number of new preprints deposited per month. (B) Preprint screening time in days. (C) License type chosen by authors. (D) Number of versions per preprint. (E) Boxplot of preprint word counts, binned by posting month. (F) Boxplot of preprint reference counts, binned by posting month. Boxplot horizontal lines denote lower quartile, median, upper quartile, with whiskers extending to 1.5*IQR. All boxplots additionally show raw data values for individual preprints with added horizontal jitter for visibility. The data underlying this figure may be found in https://github.com/preprinting-a-pandemic/pandemic_preprints and https://zenodo.org/record/4587214#.YEN22Hmnx9A. COVID-19, Coronavirus Disease 2019.
Fig 2 Comparison of the properties of COVID-19 and non-COVID-19 preprints deposited on bioRxiv and medRxiv between January 1 and October 31, 2020. (A) Number of new preprints deposited per month. (B) Preprint screening time in days. (C) License type chosen by authors. (D) Number of versions per preprint. (E) Boxplot of preprint word counts, binned by posting month. (F) Boxplot of preprint reference counts, binned by posting month. Boxplot horizontal lines denote lower quartile, median, upper quartile, with whiskers extending to 1.5*IQR. All boxplots additionally show raw data values for individual preprints with added horizontal jitter for visibility. The data underlying this figure may be found in https://github.com/preprinting-a-pandemic/pandemic_preprints and https://zenodo.org/record/4587214#.YEN22Hmnx9A. COVID-19, Coronavirus Disease 2019.CC BY · PubMed Central
Fig 3 Properties of authors of COVID-19 and non-COVID-19 preprints deposited on bioRxiv and medRxiv between January 1 and October 31, 2020. (A) Proportion of preprints with N authors. (B) Proportion of preprints deposited by country of corresponding author (top 15 countries by total preprint volume are shown). (C) Proportions of COVID-19 and non-COVID-19 corresponding authors from each of the top 15 countries shown in (B) that had previously posted a preprint (darker bar) or were posting a preprint for the first time (lighter bar). (D) Correlation between date of the first preprint originating from a country (according to the affiliation of the corresponding author) and the date of the first confirmed case from the same country for COVID-19 preprints. (E) Change in bioRxiv/medRxiv preprint posting category for COVID-19 preprint authors compared to their previous preprint (COVID-19 or non-COVID-19), for category combinations with n > = 5 authors. For all panels containing country information, labels refer to ISO 3166 character codes. The data underlying this figure may be found in https://github.com/preprinting-a-pandemic/pandemic_preprints and https://zenodo.org/record/4587214#.YEN22Hmnx9A. COVID-19, Coronavirus Disease 2019.
Fig 3 Properties of authors of COVID-19 and non-COVID-19 preprints deposited on bioRxiv and medRxiv between January 1 and October 31, 2020. (A) Proportion of preprints with N authors. (B) Proportion of preprints deposited by country of corresponding author (top 15 countries by total preprint volume are shown). (C) Proportions of COVID-19 and non-COVID-19 corresponding authors from each of the top 15 countries shown in (B) that had previously posted a preprint (darker bar) or were posting a preprint for the first time (lighter bar). (D) Correlation between date of the first preprint originating from a country (according to the affiliation of the corresponding author) and the date of the first confirmed case from the same country for COVID-19 preprints. (E) Change in bioRxiv/medRxiv preprint posting category for COVID-19 preprint authors compared to their previous preprint (COVID-19 or non-COVID-19), for category combinations with n > = 5 authors. For all panels containing country information, labels refer to ISO 3166 character codes. The data underlying this figure may be found in https://github.com/preprinting-a-pandemic/pandemic_preprints and https://zenodo.org/record/4587214#.YEN22Hmnx9A. COVID-19, Coronavirus Disease 2019.CC BY · PubMed Central
Fig 4 Publication outcomes of COVID-19 and non-COVID-19 preprints deposited on bioRxiv and medRxiv between January 1 and October 31, 2020. (A) Percentage of COVID-19 versus non-COVID-19 preprints published in peer-reviewed journals, by preprint posting month. (B) Destination journals for COVID-19 preprints that were published within our analysis period. Shown are the top 10 journals by publication volume. (C) Distribution of the number of days between posting a preprint and subsequent journal publication for COVID-19 preprints (red), non-COVID-19 preprints posted during the same period (January to October 2020) (green), and non-COVID-19 preprints posted between January and December 2019 (grey). (D) Time from posting on bioRxiv or medRxiv to publication categorised by publisher. Shown are the top 10 publishers by publication volume. Boxplot horizontal lines denote lower quartile, median, upper quartile, with whiskers extending to 1.5*IQR. All boxplots additionally show raw data values for individual preprints with added horizontal jitter for visibility. The data underlying this figure may be found in https://github.com/preprinting-a-pandemic/pandemic_preprints and https://zenodo.org/record/4587214#.YEN22Hmnx9A. COVID-19, Coronavirus Disease 2019.
Fig 4 Publication outcomes of COVID-19 and non-COVID-19 preprints deposited on bioRxiv and medRxiv between January 1 and October 31, 2020. (A) Percentage of COVID-19 versus non-COVID-19 preprints published in peer-reviewed journals, by preprint posting month. (B) Destination journals for COVID-19 preprints that were published within our analysis period. Shown are the top 10 journals by publication volume. (C) Distribution of the number of days between posting a preprint and subsequent journal publication for COVID-19 preprints (red), non-COVID-19 preprints posted during the same period (January to October 2020) (green), and non-COVID-19 preprints posted between January and December 2019 (grey). (D) Time from posting on bioRxiv or medRxiv to publication categorised by publisher. Shown are the top 10 publishers by publication volume. Boxplot horizontal lines denote lower quartile, median, upper quartile, with whiskers extending to 1.5*IQR. All boxplots additionally show raw data values for individual preprints with added horizontal jitter for visibility. The data underlying this figure may be found in https://github.com/preprinting-a-pandemic/pandemic_preprints and https://zenodo.org/record/4587214#.YEN22Hmnx9A. COVID-19, Coronavirus Disease 2019.CC BY · PubMed Central
Fig 5 Access statistics for COVID-19 and non-COVID-19 preprints posted on bioRxiv and medRxiv. (A) Boxplots of abstract views, binned by preprint posting month. (B) Boxplots of PDF downloads, binned by preprint posting month. Boxplot horizontal lines denote lower quartile, median, upper quartile, with whiskers extending to 1.5*IQR. All boxplots additionally show raw data values for individual preprints with added horizontal jitter for visibility. The data underlying this figure may be found in https://github.com/preprinting-a-pandemic/pandemic_preprints and https://zenodo.org/record/4587214#.YEN22Hmnx9A. COVID-19, Coronavirus Disease 2019.
Fig 5 Access statistics for COVID-19 and non-COVID-19 preprints posted on bioRxiv and medRxiv. (A) Boxplots of abstract views, binned by preprint posting month. (B) Boxplots of PDF downloads, binned by preprint posting month. Boxplot horizontal lines denote lower quartile, median, upper quartile, with whiskers extending to 1.5*IQR. All boxplots additionally show raw data values for individual preprints with added horizontal jitter for visibility. The data underlying this figure may be found in https://github.com/preprinting-a-pandemic/pandemic_preprints and https://zenodo.org/record/4587214#.YEN22Hmnx9A. COVID-19, Coronavirus Disease 2019.CC BY · PubMed Central
Fig 6 Usage of COVID-19 and non-COVID-19 preprints posted on bioRxiv and medRxiv between January 1 and October 31, 2020. Panels (A)–(F) show the proportion of preprints receiving at least 1 citation or mention in a given source, with the exception of panel (B) which shows the proportion of preprints receiving at least 2 tweets (to account for the fact that each preprint is tweeted once automatically by the official bioRxiv/medRxiv Twitter accounts). The inset in each panel shows a boxplot comparing citations/mentions for all COVID-19 and non-COVID-19 preprints posted within our analysis period. Boxplot horizontal lines denote lower quartile, median, upper quartile, with whiskers extending to 1.5*IQR. All boxplots additionally show raw data values for individual preprints with added horizontal jitter for visibility. Data are plotted on a log-scale with +1 added to each count for visualisation. (G) Proportion of preprints included in reference lists of policy documents from 3 sources: the ECDC, UK POST, and WHO SB. (H) Spearman correlation matrix between indicators shown in panels (A)–(F), as well as abstract views and PDF downloads for COVID-19 preprints. (I) Spearman correlation matrix between indicators shown in panels (A)–(F), in addition to abstract views and PDF downloads for non-COVID-19 preprints. The data underlying this figure may be found in https://github.com/preprinting-a-pandemic/pandemic_preprints and https://zenodo.org/record/4587214#.YEN22Hmnx9A. COVID-19, Coronavirus Disease 2019; ECDC, European Centre for Disease Prevention and Control; UK POST, United Kingdom Parliamentary Office of Science and Technology; WHO SB, World Health Organization Scientific Briefs.
Fig 6 Usage of COVID-19 and non-COVID-19 preprints posted on bioRxiv and medRxiv between January 1 and October 31, 2020. Panels (A)–(F) show the proportion of preprints receiving at least 1 citation or mention in a given source, with the exception of panel (B) which shows the proportion of preprints receiving at least 2 tweets (to account for the fact that each preprint is tweeted once automatically by the official bioRxiv/medRxiv Twitter accounts). The inset in each panel shows a boxplot comparing citations/mentions for all COVID-19 and non-COVID-19 preprints posted within our analysis period. Boxplot horizontal lines denote lower quartile, median, upper quartile, with whiskers extending to 1.5*IQR. All boxplots additionally show raw data values for individual preprints with added horizontal jitter for visibility. Data are plotted on a log-scale with +1 added to each count for visualisation. (G) Proportion of preprints included in reference lists of policy documents from 3 sources: the ECDC, UK POST, and WHO SB. (H) Spearman correlation matrix between indicators shown in panels (A)–(F), as well as abstract views and PDF downloads for COVID-19 preprints. (I) Spearman correlation matrix between indicators shown in panels (A)–(F), in addition to abstract views and PDF downloads for non-COVID-19 preprints. The data underlying this figure may be found in https://github.com/preprinting-a-pandemic/pandemic_preprints and https://zenodo.org/record/4587214#.YEN22Hmnx9A. COVID-19, Coronavirus Disease 2019; ECDC, European Centre for Disease Prevention and Control; UK POST, United Kingdom Parliamentary Office of Science and Technology; WHO SB, World Health Organization Scientific Briefs.CC BY · PubMed Central

Verification

Claims the paper makes

18 Valid · 1 Not valid · 14 Not checked · 141 Own results and interpretations

100 more claims · 6 with their cited sources checked

Create a free account to see all 174 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 30
  • It may state two separate claims as one. 47

Create a free account to see these claims.

Statistics recomputed

Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.

  • Consistentz = 125reported p < .001 · recomputed p < .001

    “z = 125.0, p < .001”

  • Consistentz = 124.2reported p < .001 · recomputed p < .001

    “z = 124.2, p < .001”

  • Consistentz = 116.3reported p < .001 · recomputed p < .001

    “z = 116.3, p < .001”

  • Consistentz = 135.7reported p < .001 · recomputed p < .001

    “z = 135.7, p < .001”

  • Consistentz = 83.3reported p < .001 · recomputed p < .001

    “z = 83.3, p < .001”

5 of 8 · the rest aren’t loaded

3 more recomputed tests

Create a free account to see every test the Stats check recomputed.

See all tests — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 6 · the rest aren’t loaded

1 more finding

Create a free account to see every finding of this check.

See all findings — free account

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 49 references

Research works printed but not linked: 5

  1. Kaiser J, 2014, Am 12:00. BioRxiv at 1 year: A promising start. In: Science | AAAS [Internet]. 11 Nov 2014 [cited 13 May 2020]. Available from: https://www.sciencemag.org/news/2014/11/biorxiv-1-year-promising-start
  2. D. Himmelstein, 2016, The licensing of bioRxiv preprints, Satoshi Village
  3. ASAPbio. Preprint authors optimistic about benefits: preliminary results from the #bioPreprints2020 survey. In: ASAPbio [Internet]. 27 Jul 2020 [cited 1 Feb 2021]. Available from: https://asapbio.org/biopreprints2020-survey-initial-results
  4. Inglis J. We’ve just put an additional, cautionary note about the use of preprints on every @biorxivpreprint https://t.co/08eSXL4dDi. In: Twitter [Internet]. 1 Feb 2020 [cited 22 May 2020]. Available from: https://twitter.com/johnringlis/status/1223598414493077505
  5. OASPA. COVID-19 Publishers Open Letter of Intent—Rapid Review. In: OASPA [Internet]. 27 May 2020 [cited 13 May 2020]. Available from: https://oaspa.org/covid-19-publishers-open-letter-of-intent-rapid-review/

Cited by

See all 555

Metadata

Authors
Fraser, N., Brierley, L., Dey, G., Polka, J. K., Pálfy, M., Nanni, F., & Coates, J. A.
Affiliations
  • ZBW – Leibniz-Informationszentrum Wirtschaft (DE)
  • University of Liverpool (GB)
  • MRC Laboratory for Molecular Cell Biology (GB)
  • ASAPbio (US)
  • Company of Biologists (GB)
  • The Alan Turing Institute (GB)
  • Queen Mary University of London (GB)
Corresponding author
Coates, Jonathon Alexis
Venue
PLOS Biology
Published
2021-04-02
Volume
19
Issue
4
Pages
e3000959
ISSN
  • 1544-9173 (ISSN-L)
  • 1545-7885
OpenAlex
W3150044582
Cited by
555
References
49
Citations by year
2026: 30 · 2025: 61 · 2024: 86 · 2023: 128 · 2022: 129 · 2021: 96
FWCI
94.62
Type
journal article
Language
en
Open access
Locations
  • PLoS Biology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ZBW Publication Archive (ZBW – Leibniz Information Centre for Economics) (acceptedVersion, cc-by)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo
Funders
  • OASE (01PU17005B, 01PU17011D)
  • Medical Research Council (MR/T027355/1)
Topics
  • Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
  • Social Sciences › Library and Information Sciences › scientometrics and bibliometrics research
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
preprints, COVID-19 research, preprint servers, bioRxiv, medRxiv, science communication, SARS-CoV-2, public engagement with science
MeSH terms
Preprints as Topic, COVID-19, SARS-CoV-2, Communication, Humans, Publishing, Peer Review, Research, Information Dissemination, Biomedical Research, Pandemics, Open Access Publishing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape. https://app.cochat.ai/papers/10.1371/journal.pbio.3000959
The paper
Fraser, N., Brierley, L., Dey, G., Polka, J. K., Pálfy, M., Nanni, F., & Coates, J. A. (2021). The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape. PLOS Biology. https://doi.org/10.1371/journal.pbio.3000959

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.